About the Program

In 2021, the Emory CFAR launched the Emory Training Program in HIV Translational Research to End the Epidemic T32 program. The program is fully administratively and scientifically integrated into the Emory CFAR to capitalize on the spectrum of ongoing HIV investigation at our institution. The T32 program focuses on translational HIV science at the epicenter of the United States HIV epidemic in the South and was built around research activities in three major focus areas including 1) Laboratory-based basic science, vaccine, and cure research, 2) Patient-centered clinical research, and 3) Public health and implementation science. Trainees will gain expertise to conduct cutting-edge HIV research through hands-on experience and formal didactics with emphasis on educating trainees in the broader context of HIV research across the translational continuum. There are five post-doctoral fellow slots for candidates with a PhD, MD, or MD/PhD degree and one pre-doctoral slot for an Emory PhD student.

Program Goals

1. To provide two years of support to five post-doctoral fellows as well as an opportunity for one pre-doctoral student with an emphasis on historically under-represented minority trainees to conduct cutting-edge HIV research through hands-on experience and formal didactics with emphasis on educating trainees in the broader context of HIV research across the translational continuum.
2. To encompass research activities in each of the NIH HIV/AIDS research priorities to reduce the incidence of HIV, develop next generation HIV therapeutics, conduct research towards an HIV cure, and address HIV associated co-morbidities, co-infections and complications; but, more importantly, our program also exposes trainees to cross-cutting areas of HIV research and team science to accelerate the translation of discovery into improved health outcomes.